| Fasting-mimicking diet and hormone therapy induce breast cancer regression I Caffa, V Spagnolo, C Vernieri, F Valdemarin, P Becherini, M Wei, ... Nature 583 (7817), 620-624, 2020 | 229 | 2020 |
| Fasting-mimicking diet and hormone therapy induce breast cancer regression I Caffa, V Spagnolo, C Vernieri, F Valdemarin, P Becherini, M Wei, ... Nature 583 (7817), 620-624, 2020 | 224 | 2020 |
| ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer G Xu, S Chhangawala, E Cocco, P Razavi, Y Cai, JE Otto, L Ferrando, ... Nature genetics 52 (2), 198-207, 2020 | 150 | 2020 |
| FOXA1 mutations reveal distinct chromatin profiles and influence therapeutic response in breast cancer A Arruabarrena-Aristorena, JLV Maag, S Kittane, Y Cai, WR Karthaus, ... Cancer Cell 38 (4), 534-550. e9, 2020 | 75 | 2020 |
| Squalene epoxidase as a promising metabolic target in cancer treatment G Cirmena, P Franceschelli, E Isnaldi, L Ferrando, M De Mariano, ... Cancer letters 425, 13-20, 2018 | 71 | 2018 |
| Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases EM da Silva, DJ Fix, APM Sebastiao, P Selenica, L Ferrando, SH Kim, ... Modern Pathology, 1-18, 2021 | 62 | 2021 |
| Whole-Exome Sequencing Analysis of the Progression from Non–Low-Grade Ductal Carcinoma In Situ to Invasive Ductal Carcinoma F Pareja, DN Brown, JY Lee, ADC Paula, P Selenica, R Bi, FC Geyer, ... Clinical Cancer Research 26 (14), 3682-3693, 2020 | 53 | 2020 |
| Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary ADC Paula, EM da Silva, SE Segura, F Pareja, R Bi, P Selenica, SH Kim, ... Modern Pathology 33 (8), 1606-1617, 2020 | 47 | 2020 |
| PAX8–GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid C Marchiò, ADC Paula, R Gularte-Merida, T Basili, A Brandes, ... Modern Pathology 32 (12), 1734-1743, 2019 | 39 | 2019 |
| Safety and feasibility of fasting-mimicking diet and effects on nutritional status and circulating metabolic and inflammatory factors in cancer patients undergoing active treatment F Valdemarin, I Caffa, A Persia, AL Cremonini, L Ferrando, L Tagliafico, ... Cancers 13 (16), 4013, 2021 | 36 | 2021 |
| Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary SH Kim, ADC Paula, T Basili, H Dopeso, R Bi, F Pareja, EM da Silva, ... Nature communications 11 (1), 1-16, 2020 | 35 | 2020 |
| Endometrial Cancers in BRCA1 or BRCA2 Germline Mutation Carriers: Assessment of Homologous Recombination DNA Repair Defects ES Smith, A Da Cruz Paula, KA Cadoo, NR Abu-Rustum, X Pei, ... JCO Precision Oncology 3, 1-11, 2019 | 31 | 2019 |
| The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas LA Moukarzel, L Ferrando, A Da Cruz Paula, DN Brown, FC Geyer, ... Molecular oncology 15 (4), 1024-1039, 2021 | 26 | 2021 |
| The genomic landscape of metastatic histologic special types of invasive breast cancer F Pareja, L Ferrando, SSK Lee, F Beca, P Selenica, DN Brown, ... NPJ breast cancer 6 (1), 1-10, 2020 | 26 | 2020 |
| Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes LA Moukarzel, ADC Paula, L Ferrando, T Hoang, APM Sebastiao, ... Modern Pathology 34 (5), 994-1007, 2021 | 24 | 2021 |
| TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer EM da Silva, P Selenica, M Vahdatinia, F Pareja, ADC Paula, L Ferrando, ... NPJ breast cancer 7 (1), 1-8, 2021 | 22 | 2021 |
| Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer E Isnaldi, A Garuti, G Cirmena, S Scabini, E Rimini, L Ferrando, M Lia, ... Journal of translational medicine 17 (1), 1-10, 2019 | 21 | 2019 |
| Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer E Isnaldi, D Ferraioli, L Ferrando, S Brohée, F Ferrando, P Fregatti, ... Breast cancer research and treatment 177 (2), 335-343, 2019 | 20 | 2019 |
| Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma L Ferrando, G Cirmena, A Garuti, S Scabini, F Grillo, L Mastracci, E Isnaldi, ... Plos one 15 (2), e0226595, 2020 | 19 | 2020 |
| Sterol synthesis pathway inhibition as a target for cancer treatment S Feltrin, F Ravera, N Traversone, L Ferrando, D Bedognetti, A Ballestrero, ... Cancer Letters 493, 19-30, 2020 | 18 | 2020 |
